Canada's Generics Export Program Falters Amid Litigation Fears
Canadian generic drug makers are opting out of the country's trailblazing efforts to supply developing countries with patented drugs, blaming excessive safeguards for patent holders under the new law, according to...To view the full article, register now.
Already a subscriber? Click here to view full article